Charles Zhou

Stock Analyst at UBS

(0.3)
# 2512
Out of 5,329 analysts
13
Total ratings
50.00%
Success rate
-7.39%
Average return
8 Stocks
Name Action PT Current % Upside Ratings Updated
FUTU Futu Hldgs
Maintains: Strong Buy
130 136
97.16 39.98% 3 Mar 17, 2025
ZYME Zymeworks
Reiterates: Buy
16
13.1 22.14% 1 Mar 8, 2023
COGT Cogent Biosciences
Initiates Coverage On: Buy
15
5.85 156.41% 1 Jun 28, 2022
MGNX Macrogenics
Downgrades: Neutral
n/a
n/a n/a 1 May 5, 2022
PMVP PMV Pharma
Initiates Coverage On: Buy
56
1.01 5444.55% 1 Aug 2, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
46
1.46 3050.68% 1 Jun 28, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Jan 22, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Neutral
n/a
n/a n/a 3 Aug 25, 2017